1. Metformin protects red blood cells against rotenone induced oxidative stress and cytotoxicity.
- Author
-
Tripathi SS, Singh AK, Akhtar F, Chaudhary A, and Rizvi SI
- Subjects
- Animals, Erythrocytes pathology, Hypoglycemic Agents pharmacology, Insecticides toxicity, Male, Rats, Rats, Wistar, Erythrocytes drug effects, Metformin pharmacology, Oxidative Stress drug effects, Protective Agents pharmacology, Rotenone toxicity
- Abstract
Context: The anti-diabetic medicine metformin has been reported as an anti-ageing drug candidate as it mimics the benefits of caloric restriction and reduces ageing-related oxidative stress in various experimental organisms., Objective: We investigated the possible anti-oxidative role of metformin against rotenone-induced oxidative stress and cytotoxicity in erythrocytes of Wistar rats. Rotenone is a well-known inducer of oxidative stress which leads to a cellular redox imbalance., Materials and Methods: We have co-exposed the experimental rats with rotenone (2.5 mg/kg, i.p.) and metformin (300 mg/kg, orally) for 30 days to investigate the protective effects of metformin on various rotenone-induced impaired oxidative stress biomarkers in rat erythrocytes., Results: We found that a significant alleviation in the levels of rotenone-induced pro-oxidant and anti-oxidant markers following exposure of metformin., Discussion and Conclusions: Our findings suggest that metformin supplementation shows a protective role in against rotenone-induced redox imbalance and cytotoxicity in rat erythrocytes.
- Published
- 2021
- Full Text
- View/download PDF